AUS
NZ
UK
CA
USA
IND
Health
Tonix Pharmaceuticals Develops Innovative Fibromyalgia Treatment
October 08, 2024 02:38 PM PDT| By Team Kalkine MediaHighlights,Tonix Pharmaceuticals' innovative drug formulation aims to improve fibromyalgia treatment by enhancing drug absorption and stability.,Ongoing unmet needs for fibromyalgia treatments continue to drive research and development in the sector....
IQVIA's Price Target Adjustments Indicate Analyst Confidence
October 08, 2024 12:38 PM PDT| By Team Kalkine MediaHeadlines,Price Target Adjustment for IQVIA,Analyst Ratings Reflect Positive Sentiment,Future Outlook for IQVIA Stock,IQVIA,(NYSE:IQV),has recently experienced a price target adjustment from analysts at Evercore ISI, which lowered the target from 270...
Pfizer’s Stock Performance: Analyst Insights and Future Outlook
October 08, 2024 12:36 PM PDT| By Team Kalkine MediaHeadlines,Pfizer experiences a slight increase in trading activity, with notable analyst upgrades.,The stock remains a subject of varied ratings from several research firms.,Analysts project a positive outlook for Pfizer's price movement based on rec...
Novo Nordisk: Positive Analyst Ratings Persist Amid Slight Price Adjustment
October 08, 2024 12:31 PM PDT| By Team Kalkine MediaHeadlines,Novo Nordisk experiences a slight decline in share price,Analysts provide updated target prices reflecting positive outlook,Consensus remains favorable despite minor trading fluctuations,Novo Nordisk,(NYSE:NVO),A/S shares traded down during...
Vivos' OSA Devices Receive AMA Support for Coverage
October 08, 2024 12:12 PM PDT| By Team Kalkine MediaHighlights,The American Medical Association's approval of new CPT codes for Vivos' devices marks a major milestone. These codes, effective next year, will facilitate streamlined insurance coverage and reimbursement for the company's FDA-cleared oral...
KindlyMD Partners with UnitedHealthcare to Expand Patient Access
October 08, 2024 07:39 AM PDT| By Team Kalkine MediaHighlights:,KindlyMD’s new contract with UnitedHealthcare will begin on November 1, 2024, enhancing patient access.,The partnership aims to reduce out-of-pocket costs for patients, promoting holistic healthcare solutions.,KindlyMD’s commitment to inn...
Precipio, Inc. Launches Enhanced Bloodhound MPN Panel to Revolutionize CALR Mutation Analysis
October 08, 2024 07:28 AM PDT| By Team Kalkine MediaHighlights,- New capabilities distinguish between CALR type 1 and type 2 mutations.,- Alignment with the latest NCCN guidelines enhances clinical decision-making.,- First quantitative PCR-based panel offering detailed CALR subtyping in MPN diagnostic...
Accolade has confirmed its results for the fiscal second quarter of 2025
October 08, 2024 06:02 AM PDT| By Team Kalkine MediaHighlights:,Accolade reported a 10% increase in revenue for fiscal Q2 2025, reaching $106.4 million, with a notable 27% improvement in net loss to $23.9 million.,Non-GAAP Adjusted EBITDA loss narrowed significantly by 68% to $2.8 million, while Adjus...
Talkiatry is enhancing its postpartum depression care services to better address maternal mental health needs
October 08, 2024 05:57 AM PDT| By Team Kalkine MediaHighlights:,Talkiatry has introduced a new initiative to support women experiencing postpartum depression (PPD) through virtual appointments with board-certified psychiatrists.,The company has launched educational resources to help identify PPD sympt...
Bio-Path Holdings has commenced the development of a therapeutic program to address obesity
October 08, 2024 05:55 AM PDT| By Team Kalkine MediaHighlights:,Bio-Path Holdings has launched a new therapeutic program for BP1001-A, targeting obesity and related metabolic diseases, marking a novel application of their DNAbilize® technology.,Enrollment is complete for the third dosing cohort in the...
Is This Company’s Financial Strategy Worth Your Watch In 2024?
October 07, 2024 01:42 PM PDT| By Team Kalkine MediaHighlights,CareCloud’s current debt load has significantly decreased compared to last year, showing efforts to reduce financial obligations.,The company’s cash reserves offset much of the debt, leaving a manageable net debt level for operations.,Whil...
Phio presents data that underscores INTASYL's significance in immune cell-mediated cancer cell destruction
October 07, 2024 06:20 AM PDT| By Team Kalkine MediaHighlights:,Phio Pharmaceuticals Corp. has unveiled data from its proprietary INTASYL platform, which effectively silences mRNA to enhance immune responses against cancer.,Key INTASYL compounds include PH-762, PH-894, PH-804, and PH-905, each targeti...
Phase 3 SAPPHIRE study results reveal that Apitegromab meets its primary endpoint in treating patients with SMA, as reported by Scholar Rock
October 07, 2024 05:53 AM PDT| By Team Kalkine MediaHighlights:,Scholar Rock announced positive topline results from the Phase 3 SAPPHIRE clinical trial for apitegromab, showing a statistically significant improvement in motor function in patients with Spinal Muscular Atrophy (SMA).,The trial met its...
Philips and Siloam Hospitals Join Forces to Advance AI in Indonesian Healthcare
October 07, 2024 05:01 AM PDT| By Team Kalkine MediaHighlights,Philips and Siloam Hospitals partner to enhance AI capabilities in Indonesian healthcare.,Collaboration aims to improve clinical outcomes and support digital transformation.,Focus on local expertise and global knowledge sharing to build a...
GE HealthCare Completes Phase I Development of Innovative Manganese-Based MRI Contrast Agent
October 07, 2024 04:56 AM PDT| By Team Kalkine MediaHighlights,GE HealthCare completes Phase I trial for innovative manganese-based MRI contrast agent.,New contrast agent shows promising safety profile, potentially reducing environmental impact.,GE HealthCare celebrates 150 years of innovation in Norw...
Supply bottlenecks lead to a downgrade for Novo Nordisk
October 07, 2024 04:13 AM PDT| By Team Kalkine MediaHighlights:,Jefferies downgrades Novo Nordisk to "underperform," citing concerns over the supply of its weight-loss drug, Wegovy, particularly in the United States.,Recent data indicates a significant decline in Wegovy prescriptions, especially for t...
A stake worth $1 billion in Pfizer is secured by activist interest Starboard Value
October 07, 2024 03:28 AM PDT| By Team Kalkine MediaHighlights:,Activist firm Starboard Value has acquired a substantial stake in Pfizer Inc and is advocating for strategic changes within the pharmaceutical company.,Starboard has engaged with former Pfizer executives to bolster its initiatives aimed a...
Rise in Futura Medical shares is attributed to receipt of $5 million US milestone payment
October 07, 2024 03:23 AM PDT| By Team Kalkine MediaHighlights:,Futura Medical PLC secures a significant milestone payment following the US launch of its erectile dysfunction gel, Eroxon.,Eroxon becomes the first over-the-counter treatment for erectile dysfunction available in the US market.,Stifel pr...
Penumbra's Path: Navigating Growth Through Capital Allocation
October 06, 2024 12:42 PM PDT| By Team Kalkine MediaHeadlines,Identifying Key Trends for Long-Term Value Growth,Analyzing Penumbra's Return on Capital Employed,Assessing Investment Strategies for Future Success,Penumbra,(NYSE:PEN),has been attracting attention in the stock market, raising questions ab...
Significant Insider Investments Highlight Confidence in Biohaven's Growth
October 06, 2024 12:13 PM PDT| By Team Kalkine MediaHeadlines,Insider Buying Indicates Confidence,Notable Transactions Over the Past Year,High Insider Ownership Reflects Alignment with Shareholders,Vladimir Coric, the Chairman and CEO of Biohaven Ltd.,(NYSE:BHVN),recently acquired a significant amount...
